Literature DB >> 24899282

Phage therapy gets revitalized.

Sara Reardon.   

Abstract

Mesh:

Year:  2014        PMID: 24899282     DOI: 10.1038/510015a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  62 in total

1.  Experimental evolution and bacterial resistance: (co)evolutionary costs and trade-offs as opportunities in phage therapy research.

Authors:  Pauline D Scanlan; Angus Buckling; Alex R Hall
Journal:  Bacteriophage       Date:  2015-05-21

2.  Targeting Enterococcus faecalis biofilms with phage therapy.

Authors:  Leron Khalifa; Yair Brosh; Daniel Gelman; Shunit Coppenhagen-Glazer; Shaul Beyth; Ronit Poradosu-Cohen; Yok-Ai Que; Nurit Beyth; Ronen Hazan
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

3.  Variation of resistance and infectivity between Pseudomonas fluorescens SBW25 and bacteriophage Φ2 and its therapeutic implications.

Authors:  Hanchen Chen; Guohua Chen
Journal:  Virol Sin       Date:  2015-02       Impact factor: 4.327

4.  Antibiotic discovery goes underground: The discovery of teixobactin could revitalise the search for new antibiotics based on the novel method the researchers used to identify the compound.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2015-04-01       Impact factor: 8.807

5.  Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.

Authors:  Lauri Mikonranta; Angus Buckling; Matti Jalasvuori; Ben Raymond
Journal:  Biol Lett       Date:  2019-03-29       Impact factor: 3.703

Review 6.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

Review 7.  Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine.

Authors:  Kegan S Sunderland; Mingying Yang; Chuanbin Mao
Journal:  Angew Chem Int Ed Engl       Date:  2017-01-24       Impact factor: 15.336

Review 8.  Microbiome therapeutics - Advances and challenges.

Authors:  Mark Mimee; Robert J Citorik; Timothy K Lu
Journal:  Adv Drug Deliv Rev       Date:  2016-05-05       Impact factor: 15.470

9.  Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection.

Authors:  Wan Beom Park; Hong Bin Kim; Nak-Hyun Kim; Jeong Eun Cho; Yoon Jeong Choi; Su Jin Choi; Soo Youn Jun; Chang Kyung Kang; Kyoung-Ho Song; Pyoeng Gyun Choe; Ji-Hwan Bang; Eu Suk Kim; Sang Won Park; Nam-Joong Kim; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

10.  Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.

Authors:  Fang Tang; Dezhi Li; Haojin Wang; Zhe Ma; Chengping Lu; Jianjun Dai
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.